Multiple officer departures filed; three small-caps face delisting pressure

Multiple officer departures filed; three small-caps face delisting pressure

A cohort of large-cap companies disclosed officer departures in early May, while smaller-cap names face mounting regulatory headwinds. Edwards Lifesciences (EW), ADT Inc. (ADT), FedEx Corp. (FDX), and Baxter International (BAX) each filed Item 5.02 disclosures on or around May 8, signaling C-suite turnover across healthcare, security, logistics, and industrial sectors. Separately, small-cap delisting risk concentrates in QETA (Quetta Acquisition Corp), SBEV (Splash Beverage Group), and LRHC (La Rosa Holdings), which have accumulated multiple Item 8.A.01 flags this week. SBEV additionally disclosed two officer departures, compounding near-term compliance risk. River Financial Corp disclosed a cybersecurity incident on July 10 under Item 1.05, though details remain limited. The officer-departure cluster across large-caps does not yet suggest systemic governance stress, but delisting pressure on QETA and SBEV warrants immediate scrutiny given their cumulative flag counts.